1. Home
  2. DCTH vs RSVR Comparison

DCTH vs RSVR Comparison

Compare DCTH & RSVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • RSVR
  • Stock Information
  • Founded
  • DCTH 1988
  • RSVR 2007
  • Country
  • DCTH United States
  • RSVR United States
  • Employees
  • DCTH N/A
  • RSVR N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • RSVR Movies/Entertainment
  • Sector
  • DCTH Health Care
  • RSVR Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • RSVR Nasdaq
  • Market Cap
  • DCTH 518.0M
  • RSVR 528.3M
  • IPO Year
  • DCTH N/A
  • RSVR N/A
  • Fundamental
  • Price
  • DCTH $12.98
  • RSVR $7.39
  • Analyst Decision
  • DCTH Strong Buy
  • RSVR Strong Buy
  • Analyst Count
  • DCTH 4
  • RSVR 1
  • Target Price
  • DCTH $22.75
  • RSVR $12.50
  • AVG Volume (30 Days)
  • DCTH 494.6K
  • RSVR 39.1K
  • Earning Date
  • DCTH 03-06-2025
  • RSVR 05-29-2025
  • Dividend Yield
  • DCTH N/A
  • RSVR N/A
  • EPS Growth
  • DCTH N/A
  • RSVR 4113.60
  • EPS
  • DCTH N/A
  • RSVR 0.12
  • Revenue
  • DCTH $37,205,000.00
  • RSVR $156,433,584.00
  • Revenue This Year
  • DCTH $112.81
  • RSVR $10.97
  • Revenue Next Year
  • DCTH $61.78
  • RSVR $6.81
  • P/E Ratio
  • DCTH N/A
  • RSVR $62.21
  • Revenue Growth
  • DCTH 1701.69
  • RSVR 11.32
  • 52 Week Low
  • DCTH $4.26
  • RSVR $6.83
  • 52 Week High
  • DCTH $16.97
  • RSVR $9.83
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 44.79
  • RSVR 45.36
  • Support Level
  • DCTH $12.18
  • RSVR $7.12
  • Resistance Level
  • DCTH $14.61
  • RSVR $7.76
  • Average True Range (ATR)
  • DCTH 0.77
  • RSVR 0.30
  • MACD
  • DCTH -0.00
  • RSVR 0.03
  • Stochastic Oscillator
  • DCTH 33.47
  • RSVR 47.89

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About RSVR Reservoir Media Inc.

Reservoir Media Inc is an independent music company. The company's segment includes Music Publishing; Recorded Music and others. It generates the maximum of its revenue from the Music Publishing segment.

Share on Social Networks: